Researchers say pharmacogenomics can assist providers in determining the best antidepressant treatments for patients with depression and avoid prescribing medications that could have adverse effects.
Including genomic sequencing with routine newborn testing could reveal the risk a child has of developing numerous conditions later in life. Researchers weigh up the pros and cons of genetic sequencing in newborns.
Based on prior findings, researchers propose that depressed levels of insulin-like growth factor (IGF) in the blood of newborns could potentially serve as a biomarker for the later development of autism.
